These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20487001)

  • 21. The inhibitory effects of antimuscarinic autoantibodies in the sera of primary Sjogren syndrome patients on the gastrointestinal motility.
    Park K; Park S; Jackson MW
    Mol Immunol; 2013 Dec; 56(4):583-7. PubMed ID: 23911416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of nitric oxide signaling through muscarinic receptors in submandibular glands by primary Sjögren syndrome antibodies.
    Pérez Leirós C; Sterin-Borda L; Hubscher O; Arana R; Borda ES
    Clin Immunol; 1999 Feb; 90(2):190-5. PubMed ID: 10080830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Signaling pathways involved in pilocarpine-induced mucin secretion in rat submandibular glands.
    Busch L; Borda E
    Life Sci; 2007 Feb; 80(9):842-51. PubMed ID: 17137604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Muscarinic acetylcholine type-3 receptor desensitization due to chronic exposure to Sjögren's syndrome-associated autoantibodies.
    Cha S; Singson E; Cornelius J; Yagna JP; Knot HJ; Peck AB
    J Rheumatol; 2006 Feb; 33(2):296-306. PubMed ID: 16465661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of anti-muscarinic autoantibodies on leukocyte function in Sjögren's syndrome.
    Namkoong E; Lee SW; Kim N; Choi Y; Park K
    Mol Immunol; 2017 Oct; 90():136-142. PubMed ID: 28750255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies raised against the second extracellular loop of the human muscarinic M3 receptor mimic functional autoantibodies in Sjögren's syndrome.
    Cavill D; Waterman SA; Gordon TP
    Scand J Immunol; 2004 Mar; 59(3):261-6. PubMed ID: 15030576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical associations of autoantibodies to human muscarinic acetylcholine receptor 3(213-228) in primary Sjogren's syndrome.
    Kovács L; Marczinovits I; György A; Tóth GK; Dorgai L; Pál J; Molnár J; Pokorny G
    Rheumatology (Oxford); 2005 Aug; 44(8):1021-5. PubMed ID: 15888503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effects of autoantibodies on the muscarinic receptors in Sjögren's syndrome.
    Li J; Ha YM; Kü NY; Choi SY; Lee SJ; Oh SB; Kim JS; Lee JH; Lee EB; Song YW; Park K
    Lab Invest; 2004 Nov; 84(11):1430-8. PubMed ID: 15448705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sjögren's syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease.
    Gao J; Killedar S; Cornelius JG; Nguyen C; Cha S; Peck AB
    J Autoimmun; 2006 Mar; 26(2):90-103. PubMed ID: 16413168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transfer of human serum IgG to nonobese diabetic Igmu null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjögren's syndrome.
    Robinson CP; Brayer J; Yamachika S; Esch TR; Peck AB; Stewart CA; Peen E; Jonsson R; Humphreys-Beher MG
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7538-43. PubMed ID: 9636185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional role of M3 muscarinic acetylcholine receptor (M3R) reactive T cells and anti-M3R autoantibodies in patients with Sjögren's syndrome.
    Sumida T; Tsuboi H; Iizuka M; Nakamura Y; Matsumoto I
    Autoimmun Rev; 2010 Jul; 9(9):615-7. PubMed ID: 20462524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostaglandin E2 modulates Na+,K+-ATPase activity in rat hippocampus: implications for neurological diseases.
    Oliveira MS; Furian AF; Rambo LM; Ribeiro LR; Royes LF; Ferreira J; Calixto JB; Otalora LF; Garrido-Sanabria ER; Mello CF
    J Neurochem; 2009 Apr; 109(2):416-26. PubMed ID: 19200345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutralization of muscarinic receptor autoantibodies by intravenous immunoglobulin in Sjögren syndrome.
    Smith AJ; Jackson MW; Wang F; Cavill D; Rischmueller M; Gordon TP
    Hum Immunol; 2005 Apr; 66(4):411-6. PubMed ID: 15866705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibodies interfering with the type 3 muscarinic receptor pathway inhibit gastrointestinal motility and cholinergic neurotransmission in Sjögren's syndrome.
    Park K; Haberberger RV; Gordon TP; Jackson MW
    Arthritis Rheum; 2011 May; 63(5):1426-34. PubMed ID: 21312189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of anti-type 3 muscarinic acetylcholine receptor autoantibodies in the sera of Sjögren's syndrome patients by use of a transfected cell line assay.
    Gao J; Cha S; Jonsson R; Opalko J; Peck AB
    Arthritis Rheum; 2004 Aug; 50(8):2615-21. PubMed ID: 15334476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Demonstration of autoantibody binding to muscarinic acetylcholine receptors in the salivary gland in primary Sjögren's syndrome.
    Kovács L; Fehér E; Bodnár I; Marczinovits I; Nagy GM; Somos J; Boda V
    Clin Immunol; 2008 Aug; 128(2):269-76. PubMed ID: 18508410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The clinical significance of autoantibodies against acetylcholine muscarinic 3 receptor in primary Sjögren's syndrome].
    Wu Y; Li MT; Zhao Y; Feng S; Su L; Dong Y
    Zhonghua Nei Ke Za Zhi; 2008 Jul; 47(7):563-5. PubMed ID: 19035167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjögren's syndrome compared with non-Sjögren's sicca syndrome.
    van Woerkom JM; Kruize AA; Wenting-van Wijk MJ; Knol E; Bihari IC; Jacobs JW; Bijlsma JW; Lafeber FP; van Roon JA
    Ann Rheum Dis; 2005 Oct; 64(10):1474-9. PubMed ID: 15817659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholinergic submandibular effects and muscarinic receptor expression in blood vessels of the rat.
    Ryberg AT; Selberg H; Soukup O; Gradin K; Tobin G
    Arch Oral Biol; 2008 Jul; 53(7):605-16. PubMed ID: 18329001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoantibodies in primary Sjögren's syndrome: new insights into mechanisms of autoantibody diversification and disease pathogenesis.
    Gordon TP; Bolstad AI; Rischmueller M; Jonsson R; Waterman SA
    Autoimmunity; 2001; 34(2):123-32. PubMed ID: 11905842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.